跳至主要内容
临床试验/CTRI/2010/091/000174
CTRI/2010/091/000174已完成3 期

An open labeled, randomized, comparative study to evaluate efficacy and safety of fixed dose combination of Ceftriaxone + Sulbactam (CSE-1034) vs Ceftriaxone in subjects suffering from various bacterial infections.

Venus Remedies Limited0 个研究点目标入组 654 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
654

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male and female subjects in the age group of 12-65 years
  • Clinically diagnosed subjects with Urinary Tract Infection, Skin and skin structure infections, Bone and joint infections, Septicemia, Surgical prophylaxis, acute bacterial ottitis media, Meningitis,LRTI(Lower respiratory tract infections)
  • Adult patient willing to give written informed consent. Parent or LAR of minor patients ready to give written informed consent.

排除标准

  • History of hypersensitivity reaction or any specific contraindication to pencillin group of drugs or cephalosporins or ceftriaxone and sulbactam.
  • Presence of hepatic or renal disorder
  • History of hearing loss
  • Pregnant and lactating women

研究者

相似试验